New Prostate Cancer Immunotherapy Makes Tumor Work Against Itself
Injecting poly-ICLC directly into prostate tumors before surgery may reawaken immune activity and help transform resistant “cold” tumors into immune-responsive ones.
Medindia is aligned with the United Nations Sustainable Development Goals (SDGs), including SDG 3, 4, 5, 6, 10, and 12.
Disclaimer: Information on this site is for informational and educational purposes only and should not be used for diagnosis or treatment of any health-related condition or disease.
Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment.
© 1997 - 2025 Medindia. All Rights Reserved.
Author's summary: New immunotherapy helps tumors fight themselves.
More News
- €377 billion for weapons–Germany’s most extensive rearmament programme since Hitler
- Dodgers Cement Dynasty with Back-to-Back World Series Wins
- Democrats in Disarray: Internal Conflict Fuels Chaos
- Building Donor Communities for New or Underfunded Issues (SSIR)
- BMA says Government’s suggested pay rise for doctors in 2026 is indefensible - BMA media centre - BMA
- 'Argentina gradually joins the great authoritarian wave sweeping the globe'
- Solicitor judge reappointed as senior judicial commissioner
- Educators and students speak out against pro-business, militarist assault on Australian university jobs
- The Future of Palestine Solidarity in US Labor Will Come From the Rank and File
- Doctors prepare to vote for better pay